Literature DB >> 7774624

Generation of antigen-specific CD4+ T cell lines from naive precursors.

A Mehta-Damani1, S Markowicz, E G Engleman.   

Abstract

The conditions required for sensitizing naive T cells to nominal antigen are poorly understood. In this report we describe an in vitro system for generating antigen-specific CD4+ T cells from previously unprimed individuals. Freshly isolated CD4+ T cells were cultured with keyhole limpet hemocyanin (KLH), sperm whale myoglobin (SWM), or human immunodeficiency virus (HIV) gp160, antigens to which most persons have not been sensitized, in the presence of either dendritic cells (DC) or macrophages (M phi). In short-term (< 8 days) cultures, CD4+ T cells or their CD4+, CD45RA (naive) subpopulation mounted significant proliferative responses to KLH, SWM, and HIV gp160, but only if the antigens were presented by DC. In contrast, CD4+, CD45RO (memory) T cells responded poorly to these antigens, although they responded vigorously to tetanus toxoid, a recall antigen, presented by either DC or M phi. KLH- and SWM-specific CD4+ T cell lines were established from the starting population that had been sensitized in vitro, following repeated stimulation with antigen and M phi in medium supplemented with interleukin-2 and interleukin-4. Despite the continued presence of these cytokines during T cell expansion, the expanded lines retained their ability to respond to the priming antigen in the absence of exogenous cytokines. When the CD45RA and CD45RO subpopulations were sensitized and expanded separately, the CD45RA cells alone gave rise to antigen-specific T cell lines, while the CD45RO cells proliferated nonspecifically. These results demonstrate that human naive CD4+ T cells can be sensitized in vitro to nominal antigens presented by DC and that the sensitized cells can be expanded into long-term lines that retain their antigen specificity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774624     DOI: 10.1002/eji.1830250511

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients.

Authors:  Sergiusz Markowicz; Zbigniew I Nowecki; Piotr Rutkowski; Andrzej W Lipkowski; Marzena Biernacka; Anna Jakubowska-Mucka; Tomasz Switaj; Aleksandra Misicka; Henryk Skurzak; Hanna Polowniak-Pracka; Jan Walewski
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

Review 2.  Dendritic cell-based vaccines: barriers and opportunities.

Authors:  Jessica A Cintolo; Jashodeep Datta; Sarah J Mathew; Brian J Czerniecki
Journal:  Future Oncol       Date:  2012-10       Impact factor: 3.404

Review 3.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.

Authors:  L Toujas; J G Delcros; E Diez; N Gervois; G Semana; G Corradin; F Jotereau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

5.  Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.

Authors:  M Poss; J Overbaugh
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Human T lymphocyte priming in vitro by haptenated autologous dendritic cells.

Authors:  T Rustemeyer; S De Ligter; B M Von Blomberg; P J Frosch; R J Scheper
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 7.  Dendritic cells: potential role in cancer therapy.

Authors:  E G Engleman
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

8.  Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells.

Authors:  Bonnie A Colleton; Xiao-Li Huang; Nada M Melhem; Zheng Fan; Luann Borowski; Giovanna Rappocciolo; Charles R Rinaldo
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

9.  Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.

Authors:  Sara Venturini; Donald E Mosier; Dennis R Burton; Pascal Poignard
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

Authors:  D H Dockrell; A D Badley; J S Villacian; C J Heppelmann; A Algeciras; S Ziesmer; H Yagita; D H Lynch; P C Roche; P J Leibson; C V Paya
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.